Literature DB >> 10556655

Effect of six steroidal saponins isolated from anemarrhenae rhizoma on platelet aggregation and hemolysis in human blood.

J Zhang1, Z Meng, M Zhang, D Ma, S Xu, H Kodama.   

Abstract

Six steroidal saponins were isolated from Anemarrhena asphodeloides Bunge (Liliaceae), a traditional chinese medicine, and named anemarrhenasaponin I (An-I), anemarrhenasaponin Ia (An-Ia), timosaponin B-I (TB-I), timosaponin B-II (TB-II), timosaponin B-III (TB-III), and timosaponin A-III (TA-III). The effects of these six compounds on platelet aggregation and hemolysis in human blood were studied. All these compounds provoked remarkable inhibiting effect on platelet aggregation, and activated partial thromboplastin times (APTT) are sensitive to the presence of these six compounds. Using an in vitro system, APTT was delayed with the increment of the concentrations of these six compounds. In these six compounds, only timosaponin A-III appeared a strong effect on hemolysis, and anemarrhenasaponin Ia had a slight effect on hemolysis, other had no effect on hemolysis. These results suggested that these steroidal saponins isolated from Anemarrhena asphodeloides Bunge (Liliaceae) might be used as a novel antithrombotic therapeutic agents in post-myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556655     DOI: 10.1016/s0009-8981(99)00160-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  A sensitive indirect competitive enzyme-linked immunosorbent assay for the detection of sarsasapogenin in rat plasma.

Authors:  Jing Wang; Ji-hua Liu; Xu Guo; Jian Zhang; Bo-yang Yu
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

2.  Characterization of steroidal saponins from Dioscorea villosa and D. cayenensis using ultrahigh performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry.

Authors:  Bharathi Avula; Yan-Hong Wang; Mei Wang; Zulfiqar Ali; Troy J Smillie; Jerry Zweigenbaum; Ikhlas A Khan
Journal:  Planta Med       Date:  2014-02-07       Impact factor: 3.352

3.  Molecular identification of oriental medicinal plant Anemarrhena asphodeloides Bunge ('Jimo') by multiplex PCR.

Authors:  Baigalmaa Jigden; Hongtao Wang; Narantuya Samdan; Deok-Chun Yang
Journal:  Mol Biol Rep       Date:  2009-08-18       Impact factor: 2.316

4.  Shengjie Tongyu Granule Inhibits Vascular Remodeling in ApoE-Gene-Knockout Mice.

Authors:  Min Chen; Wenli Cheng; Zaixiang Shi; Nishihara Tatsukazu; Tongliang Zhou; Hong Li; Jian Guo
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-28       Impact factor: 2.629

5.  A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer's Disease.

Authors:  Yu Sun; Ying Peng; Lin-Guang Li; Li-Wei Zheng; Dong-Ju Lin; Ling-Zhi Li; Shao-Jiang Song
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-17       Impact factor: 2.629

6.  Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress.

Authors:  Frank W King; Sylvia Fong; Chandi Griffin; Mark Shoemaker; Rick Staub; Yan-Ling Zhang; Isaac Cohen; Emma Shtivelman
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

7.  Pennogenin tetraglycoside induces rat myometrial contraction and MLC20 phosphorylation via PLC-IP(3) and RhoA/Rho kinase signaling pathways.

Authors:  Limei Wang; Chao Jia; Zuyin Yu; Xiaolan Liu; Liping Kang; Yue Cong; Yajun Shan; Zhenhu Zhao; Baiping Ma; Yuwen Cong
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

8.  Isolation, Purification, Characterization and Effect upon HepG2 Cells of Anemaran from Rhizome Anemarrhena.

Authors:  Qian-Qian Jiang; Yun-Ping Zhao; Wen-Yuan Gao; Xia Li; Lu-Qi Huang; Pei-Gen Xiao
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

9.  Natural plant products in treatment of pulmonary arterial hypertension.

Authors:  Lili Xiang; Ying Li; Xu Deng; Djuro Kosanovic; Ralph Theo Schermuly; Xiaohui Li
Journal:  Pulm Circ       Date:  2018-06-05       Impact factor: 3.017

10.  Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII.

Authors:  Lu Lu; Yue Ding; Yong Zhang; Rodney Jy Ho; Yuan Zhao; Tong Zhang; Chunrong Guo
Journal:  Int J Nanomedicine       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.